Replies to post #5334 on Galena Biopharma fka GALE

[Miguel1]

At least this guy Aferiat sees growth in the coming year.
Maybe they have muzzled AF for a while. Put him on some meds or something


But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, GALENA BIOPHARMA INC reported poor results of -$0.79 versus -$0.62 in the prior year. This year, the market expects an improvement in earnings (-$0.30 versus -$0.79).